Latest news
Percheron Therapeutics (ASX:PER): Why Is Clinical Progress in Focus? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 02:26:00 GMTCeretas (ASX:CTS) Brings Alzheimer’s Ultrasound Venture to the ASX After A$8m IPO—Can Clinical Progress Drive Long-Term Value? - kalkine.com.aukalkine.com.au · Tue, 28 Jul 2026 13:10:00 GMT